Zhang D Y, Ye R G, Li Y J
Renal Research Institute, Sun Yat-Sen University of Medical Sciences, Guangzhou.
Zhonghua Nei Ke Za Zhi. 1994 May;33(5):309-12.
Serum and urine soluble interleukin-2 receptor (SIL-2R) levels were determined with ELISA method in 36 cases of nephrotic syndrome in order to investigate the significance of the change of SIL-2R level. The results showed the values in nephrotic stage group (n = 22) exceeded those in nephrotic stage remission group (n = 14, P < 0.01) and those in healthy controls (n = 20, P < 0.01). However, there was no difference of SIL-2R values either in serum or urine between nephrotic stage remission group and healthy controls (P > 0.05). Serum SIL-2R values were correlated with those of serum creatinine (r = 0.44, P < 0.01) and urine SIL-2R values were correlated with those of urine protein excretion (r = 0.48, P < 0.01). The study suggests that increased concentration of SIL-2R can serve as an indicator of nephrotic syndrome activation and/or exacerbation of renal dysfunction.
采用酶联免疫吸附测定法(ELISA法)检测了36例肾病综合征患者血清和尿液中可溶性白细胞介素-2受体(SIL-2R)水平,以探讨SIL-2R水平变化的意义。结果显示,肾病期组(n = 22)的SIL-2R水平高于肾病缓解期组(n = 14,P < 0.01)和健康对照组(n = 20,P < 0.01)。然而,肾病缓解期组与健康对照组之间血清和尿液中的SIL-2R水平均无差异(P > 0.05)。血清SIL-2R水平与血清肌酐水平相关(r = 0.44,P < 0.01),尿液SIL-2R水平与尿蛋白排泄量相关(r = 0.48,P < 0.01)。该研究提示,SIL-2R浓度升高可作为肾病综合征激活和/或肾功能恶化的指标。